These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1631 related articles for article (PubMed ID: 28976959)

  • 1. RNA targeting with CRISPR-Cas13.
    Abudayyeh OO; Gootenberg JS; Essletzbichler P; Han S; Joung J; Belanto JJ; Verdine V; Cox DBT; Kellner MJ; Regev A; Lander ES; Voytas DF; Ting AY; Zhang F
    Nature; 2017 Oct; 550(7675):280-284. PubMed ID: 28976959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells.
    Lin P; Qin S; Pu Q; Wang Z; Wu Q; Gao P; Schettler J; Guo K; Li R; Li G; Huang C; Wei Y; Gao GF; Jiang J; Wu M
    Mol Cell; 2020 Jun; 78(5):850-861.e5. PubMed ID: 32348779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmable RNA targeting with the single-protein CRISPR effector Cas7-11.
    Özcan A; Krajeski R; Ioannidi E; Lee B; Gardner A; Makarova KS; Koonin EV; Abudayyeh OO; Gootenberg JS
    Nature; 2021 Sep; 597(7878):720-725. PubMed ID: 34489594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector.
    Abudayyeh OO; Gootenberg JS; Konermann S; Joung J; Slaymaker IM; Cox DB; Shmakov S; Makarova KS; Semenova E; Minakhin L; Severinov K; Regev A; Lander ES; Koonin EV; Zhang F
    Science; 2016 Aug; 353(6299):aaf5573. PubMed ID: 27256883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. tRNA anticodon cleavage by target-activated CRISPR-Cas13a effector.
    Jain I; Kolesnik M; Kuznedelov K; Minakhin L; Morozova N; Shiriaeva A; Kirillov A; Medvedeva S; Livenskyi A; Kazieva L; Makarova KS; Koonin EV; Borukhov S; Severinov K; Semenova E
    Sci Adv; 2024 Apr; 10(17):eadl0164. PubMed ID: 38657076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for self-cleavage prevention by tag:anti-tag pairing complementarity in type VI Cas13 CRISPR systems.
    Wang B; Zhang T; Yin J; Yu Y; Xu W; Ding J; Patel DJ; Yang H
    Mol Cell; 2021 Mar; 81(5):1100-1115.e5. PubMed ID: 33472057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Bacterial Enzyme Cas13 Interferes with Neurite Outgrowth from Cultured Cortical Neurons.
    Wu QW; Kapfhammer JP
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33916905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR-Cas Systems.
    O'Connell MR
    J Mol Biol; 2019 Jan; 431(1):66-87. PubMed ID: 29940185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of Cas13a inhibition by anti-CRISPR proteins from Leptotrichia prophages.
    Johnson MC; Hille LT; Kleinstiver BP; Meeske AJ; Bondy-Denomy J
    Mol Cell; 2022 Jun; 82(11):2161-2166.e3. PubMed ID: 35623354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cas13b Is a Type VI-B CRISPR-Associated RNA-Guided RNase Differentially Regulated by Accessory Proteins Csx27 and Csx28.
    Smargon AA; Cox DBT; Pyzocha NK; Zheng K; Slaymaker IM; Gootenberg JS; Abudayyeh OA; Essletzbichler P; Shmakov S; Makarova KS; Koonin EV; Zhang F
    Mol Cell; 2017 Feb; 65(4):618-630.e7. PubMed ID: 28065598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a.
    Liu L; Li X; Ma J; Li Z; You L; Wang J; Wang M; Zhang X; Wang Y
    Cell; 2017 Aug; 170(4):714-726.e10. PubMed ID: 28757251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors.
    Konermann S; Lotfy P; Brideau NJ; Oki J; Shokhirev MN; Hsu PD
    Cell; 2018 Apr; 173(3):665-676.e14. PubMed ID: 29551272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection.
    East-Seletsky A; O'Connell MR; Knight SC; Burstein D; Cate JH; Tjian R; Doudna JA
    Nature; 2016 Oct; 538(7624):270-273. PubMed ID: 27669025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA virus interference via CRISPR/Cas13a system in plants.
    Aman R; Ali Z; Butt H; Mahas A; Aljedaani F; Khan MZ; Ding S; Mahfouz M
    Genome Biol; 2018 Jan; 19(1):1. PubMed ID: 29301551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cas13d Is a Compact RNA-Targeting Type VI CRISPR Effector Positively Modulated by a WYL-Domain-Containing Accessory Protein.
    Yan WX; Chong S; Zhang H; Makarova KS; Koonin EV; Cheng DR; Scott DA
    Mol Cell; 2018 Apr; 70(2):327-339.e5. PubMed ID: 29551514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA Targeting by Functionally Orthogonal Type VI-A CRISPR-Cas Enzymes.
    East-Seletsky A; O'Connell MR; Burstein D; Knott GJ; Doudna JA
    Mol Cell; 2017 May; 66(3):373-383.e3. PubMed ID: 28475872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA Binding and HEPN-Nuclease Activation Are Decoupled in CRISPR-Cas13a.
    Tambe A; East-Seletsky A; Knott GJ; Doudna JA; O'Connell MR
    Cell Rep; 2018 Jul; 24(4):1025-1036. PubMed ID: 30044970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in CRISPR-Cas systems for RNA targeting, tracking and editing.
    Wang F; Wang L; Zou X; Duan S; Li Z; Deng Z; Luo J; Lee SY; Chen S
    Biotechnol Adv; 2019; 37(5):708-729. PubMed ID: 30926472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective RNA Knockdown Using CRISPR-Cas13a and Molecular Targeting of the
    Saifullah ; Sakari M; Suzuki T; Yano S; Tsukahara T
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of the CRISPR-Cas13a system in fission yeast and its repurposing for precise RNA editing.
    Jing X; Xie B; Chen L; Zhang N; Jiang Y; Qin H; Wang H; Hao P; Yang S; Li X
    Nucleic Acids Res; 2018 Sep; 46(15):e90. PubMed ID: 29860393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 82.